SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- Lula, Brazil's iconic working class president, wins historic fourth term in dramatic comeback
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Accenture shares fall on insider sales and analyst downgrade
- Wall Street closes lower to end rocky week
- Credo Technology shares fall on competition concerns
Surgery Partners (SGRY) guidance reaffirmation 'positive' despite no Bain deal - Mizuho
June 17, 2025 3:22 PM EDTMizuho analyst Ann Hynes reiterated an Outperform rating and a $28.00 price target on Surgery Partners (NASDAQ: SGRY) amid today's sell-off, following the company's announcement that it has concluded its discussions with Bain Capital regarding a potential acquisition. The company's independent committee determined that its long-term potential as an independent, publicly-traded company... More



